PDS Biotech (PDSB) Overview: Cancer Immunotherapies

Schwab Network

English - June 17, 2021 18:46 - 4 minutes - 24.9 MB - ★★★★★ - 23 ratings
News Commentary News Business News business news news commentary news Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: The Fed's Latest Comments

Next Episode: Why Investors Should Await More Attractive Entry Points For Securities, Asset Classes

PDS Biotech (PDSB) is a clinical-stage immunotherapy company that has a growing pipeline of cancer immunotherapies and infectious disease vaccines. Frank Bedu-Addo, President and CEO of PDS Biotech, gives an overview of PDS Biotech, highlighting its new cancer drug, Versamune, which effectively delivers disease-specific antigens for in vivo uptake and processing. Tune in to find out more.